Achieve Life Sciences Investor Relations Material
Latest events
Q4 2023
Achieve Life Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Achieve Life Sciences Inc
Access all reports
Achieve Life Sciences Inc. is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel small molecules for treating diseases with high unmet need. Cytisinicline is our next-generation smoking cessation treatment; it has been developed to address many of the known causes of relapse associated with quitting smoking, including short-term nicotine withdrawal symptoms and long-term craving for cigarettes.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States